Sara Gianella Weibel

Title(s)Associate Adjunct Professor, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
ORCID ORCID Icon0000-0002-9927-0849 Additional info
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Sara Gianella Weibel, M.D., graduated from the University of Zurich (Switzerland). After her residency in Internal Medicine in Switzerland, she began her fellowship in the Department of Infectious Disease and Hospital Epidemiology of the University Hospital of Zurich in 2007. She moved to UC San Diego in 2009 to work as a postdoctoral fellow with Drs. Douglas Richman and Davey Smith, and joined the faculty of the Department of Medicine (Division of Infectious Diseases and Global Public Health) in 2013.

    Currently she works both at the UC San Diego Antiviral Research Center, and in her laboratory on the UC San Diego campus, where she oversees bench research. She is the director of the Center for AIDS Research (CFAR) Translational Virology Core and director of the AIDS Clinical Trial Group (ACTG) Virology Specialty Laboratory, where she serves as part of several clinical trial protocol teams. She is also co-directing the NeuroVirology and Biology Core at the HIV NeuroBehavioral Research Center as well as the HIV and Other Pandemics (HOPE) T32 Training program.

    As a "jack of all trades", Dr. Gianella has a broad background in clinical and translational virology, molecular biology and immunology. She is interested in applying the latest laboratory techniques and rigorous analytical methods to address some of the most pressing problems in infectious
    diseases. Her research includes investigating HIV persistence in various tissues and anatomical compartments across the human body and she is involved in the end-of-life Last Gift program. She is interested in understanding the transmission dynamics of HIV in the genital tract and its interactions with co-infecting viruses, especially but not limited to Cytomegalovirus. She is committed in contributing to understand sex and gender differences in HIV pathogenesis and persistence. Finally, she is investigating clinical complications related to persistent
    immune activation.

    Her team continuously strive to enhance the diversity of the biomedical workforce to improve educational experiences, fostering scientific discovery and innovation, enhancing the benefit of research on health disparate populations, and increasing public trust across the community.

    See for more details

    Collapse ORNG Applications 
    Collapse Faculty Mentoring